Eden Research plc (EDEN) Ordinary 1p
0.1p
(2.60%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.1p
(2.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.1p
(2.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
3.90p
4.05p
7.25p
£21.07 million
3.85p
3.86p
3.50p
n/a
0.05p (1.28%) Previous:
0.05p
98,880
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 3.19 | 1.83 |
| Profit before tax (£m) | (6.92) | (2.57) |
| Adjusted EPS (p): | (1.54) | (0.59) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Eden Research gets approval for Novellus+ in Mexico
20 December 2024 10:35
-
Eden Research fungicide added to German organics list
11 December 2024 13:52
-
Eden Research product granted temporary approval in Greece
2 September 2024 12:10
-
Regulatory approval for Novellus+ in Mexico
20 December 2024 07:00
-
Appointment of Distributor in Austria
16 December 2024 07:00
-
Mevalone Organic Input Registration in Germany
11 December 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.